Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimen.

G Bolis; G Scarfone; L Luchini; C Ferraris; F Zanaboni; M Presti; G Giardina; A Villa; F Parazzini

doi:10.1016/0959-8049(94)e0125-n

Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimen.

Identifier:nobleid.org/w1/20260515/3BFDCC76

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3BFDCC76.svg?ark=w1%2F20260515%2F3BFDCC76)](https://nobleid.org/work/w1/20260515/3BFDCC76)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Response to second-line weekly cisplatin chemotherapy in ovarian cancer previously treated with a cisplatin- or carboplatin-based regimen.

Identifier:nobleid.org/w1/20260515/3BFDCC76

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

View Original Paper Source

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/3BFDCC76.svg?ark=w1%2F20260515%2F3BFDCC76)](https://nobleid.org/work/w1/20260515/3BFDCC76)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work